Management believes the initiative could represent a potential $414 million five-year revenue opportunity for Callan JMB while helping establish a next-generation pharmaceutical manufacturing ecosystem in the United States.

MARION, Ala., July 16, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced a strategic partnership with Alabama State University (ASU) to support the development of an integrated pharmaceutical manufacturing ecosystem designed to strengthen domestic pharmaceutical production, enhance supply chain resilience, advance workforce development, and improve national medical preparedness.

Under the partnership, Callan JMB would provide the operational infrastructure supporting future pharmaceutical manufacturing activities, including logistics, regulatory compliance, warehousing, facility leasing, supply chain management, housing support, and related operational services. Under the terms of the agreement, Callan JMB would receive 21% of the gross revenue generated by qualifying pharmaceutical manufacturing operations.

While the initiative remains in its early stages, management believes the collaboration has the potential to become a meaningful long-term growth opportunity for the Company. Based on current development assumptions and subject to successful execution, management believes pharmaceutical manufacturing activities supported by the initiative could ultimately generate annual gross revenues approaching $500 million. At that level, Callan JMB's 21% participation could represent approximately $105 million in annual revenue to the Company.

The initiative is intended to establish a scalable pharmaceutical manufacturing ecosystem capable of supporting domestic manufacturing, research, quality assurance and quality control (QA/QC), workforce development, cold chain logistics, warehousing, and secure pharmaceutical distribution. If successfully developed, the collaboration could strengthen U.S. pharmaceutical supply chain resilience while creating new economic and educational opportunities throughout Alabama.